530 related articles for article (PubMed ID: 36239875)
1. CRISPR/Cas systems usher in a new era of disease treatment and diagnosis.
Li R; Wang Q; She K; Lu F; Yang Y
Mol Biomed; 2022 Oct; 3(1):31. PubMed ID: 36239875
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in stem cells and gene editing: Drug discovery and therapeutics.
Bayarsaikhan D; Bayarsaikhan G; Lee B
Prog Mol Biol Transl Sci; 2021; 181():231-269. PubMed ID: 34127195
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in CRISPR technologies for genome editing.
Song M; Koo T
Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
5. Genome Editing in Bacteria: CRISPR-Cas and Beyond.
Arroyo-Olarte RD; Bravo Rodríguez R; Morales-Ríos E
Microorganisms; 2021 Apr; 9(4):. PubMed ID: 33920749
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives.
Dong W; Kantor B
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372494
[TBL] [Abstract][Full Text] [Related]
7. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for
Wei T; Cheng Q; Farbiak L; Anderson DG; Langer R; Siegwart DJ
ACS Nano; 2020 Aug; 14(8):9243-9262. PubMed ID: 32697075
[TBL] [Abstract][Full Text] [Related]
8. [CRISPR/Cas-mediated DNA base editing technology and its application in biomedicine and agriculture].
Yu C; Mo J; Zhao X; Li G; Zhang X
Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3071-3087. PubMed ID: 34622618
[TBL] [Abstract][Full Text] [Related]
9. Precision genome editing in the eye.
Suh S; Choi EH; Raguram A; Liu DR; Palczewski K
Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2210104119. PubMed ID: 36122230
[TBL] [Abstract][Full Text] [Related]
10. Progress and challenges towards CRISPR/Cas clinical translation.
Rosenblum D; Gutkin A; Dammes N; Peer D
Adv Drug Deliv Rev; 2020; 154-155():176-186. PubMed ID: 32659256
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas-Dependent and Nuclease-Free
Dasgupta I; Flotte TR; Keeler AM
Hum Gene Ther; 2021 Mar; 32(5-6):275-293. PubMed ID: 33750221
[TBL] [Abstract][Full Text] [Related]
12. CRISPR Technology in Gene-Editing-Based Detection and Treatment of SARS-CoV-2.
Shademan B; Nourazarian A; Hajazimian S; Isazadeh A; Biray Avci C; Oskouee MA
Front Mol Biosci; 2021; 8():772788. PubMed ID: 35087864
[TBL] [Abstract][Full Text] [Related]
13. Application of CRISPR-Cas systems in neuroscience.
Bonnerjee D; Bagh S
Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599
[TBL] [Abstract][Full Text] [Related]
14. Versatile and multifaceted CRISPR/Cas gene editing tool for plant research.
Pandey PK; Quilichini TD; Vaid N; Gao P; Xiang D; Datla R
Semin Cell Dev Biol; 2019 Dec; 96():107-114. PubMed ID: 31022459
[TBL] [Abstract][Full Text] [Related]
15. Applications of CRISPR-Cas in agriculture and plant biotechnology.
Zhu H; Li C; Gao C
Nat Rev Mol Cell Biol; 2020 Nov; 21(11):661-677. PubMed ID: 32973356
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
17. Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.
Song X; Liu C; Wang N; Huang H; He S; Gong C; Wei Y
Adv Drug Deliv Rev; 2021 Jan; 168():158-180. PubMed ID: 32360576
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas systems: Challenges and future prospects.
Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
[TBL] [Abstract][Full Text] [Related]
19. Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications.
Masarwy R; Stotsky-Oterin L; Elisha A; Hazan-Halevy I; Peer D
Adv Drug Deliv Rev; 2024 Jun; 211():115359. PubMed ID: 38857763
[TBL] [Abstract][Full Text] [Related]
20. CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants.
Abdullah ; Jiang Z; Hong X; Zhang S; Yao R; Xiao Y
Synth Syst Biotechnol; 2020 Dec; 5(4):277-292. PubMed ID: 32954022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
